These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 28929632)

  • 1. Vasopressin: novel roles for a new hormone - Emerging therapies in cardiometabolic and renal diseases.
    Melander O
    J Intern Med; 2017 Oct; 282(4):281-283. PubMed ID: 28929632
    [No Abstract]   [Full Text] [Related]  

  • 2. Copeptin: a biomarker of cardiovascular and renal function.
    Morgenthaler NG
    Congest Heart Fail; 2010 Jul; 16 Suppl 1():S37-44. PubMed ID: 20653710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasopressin and Vasopressin Antagonists in Heart Failure.
    Vishram-Nielsen JK; Gustafsson F
    Handb Exp Pharmacol; 2017; 243():307-328. PubMed ID: 28432473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The vasopressin system: new insights for patients with kidney diseases: Epidemiological evidence and therapeutic perspectives.
    Clark WF; Devuyst O; Roussel R
    J Intern Med; 2017 Oct; 282(4):310-321. PubMed ID: 28905441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copeptin, a marker of vasopressin, in abdominal obesity, diabetes and microalbuminuria: the prospective Malmö Diet and Cancer Study cardiovascular cohort.
    Enhörning S; Bankir L; Bouby N; Struck J; Hedblad B; Persson M; Morgenthaler NG; Nilsson PM; Melander O
    Int J Obes (Lond); 2013 Apr; 37(4):598-603. PubMed ID: 22614056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasopressin Antagonists.
    Vandergheynst F; Gankam Kengne F; Decaux G
    N Engl J Med; 2015 Sep; 373(10):980-1. PubMed ID: 26332562
    [No Abstract]   [Full Text] [Related]  

  • 7. Vasopressin Antagonists.
    Berl T
    N Engl J Med; 2015 Sep; 373(10):981. PubMed ID: 26332561
    [No Abstract]   [Full Text] [Related]  

  • 8. Vasopressin antagonists.
    Berl T
    N Engl J Med; 2015 Jun; 372(23):2207-16. PubMed ID: 26039601
    [No Abstract]   [Full Text] [Related]  

  • 9. Copeptin in the diagnosis of vasopressin-dependent disorders of fluid homeostasis.
    Christ-Crain M; Fenske W
    Nat Rev Endocrinol; 2016 Mar; 12(3):168-76. PubMed ID: 26794439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnostic and prognostic value of copeptin in cardiovascular disease, current status, and prospective.
    Parizadeh SM; Ghandehari M; Parizadeh MR; Ferns GA; Ghayour-Mobarhan M; Avan A; Hassanian SM
    J Cell Biochem; 2018 Nov; 119(10):7913-7923. PubMed ID: 30011137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significant first presence of Mg Symposium at Experimental Biology, a large USA conference.
    Rosanoff A
    Magnes Res; 2010 Dec; 23(4):S180. PubMed ID: 21233057
    [No Abstract]   [Full Text] [Related]  

  • 12. Copeptin, a stable peptide derived from the vasopressin precursor, correlates with the individual stress level.
    Katan M; Morgenthaler N; Widmer I; Puder JJ; König C; Müller B; Christ-Crain M
    Neuro Endocrinol Lett; 2008 Jun; 29(3):341-6. PubMed ID: 18580851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasopressin: physiology, assessment and osmosensation.
    Bankir L; Bichet DG; Morgenthaler NG
    J Intern Med; 2017 Oct; 282(4):284-297. PubMed ID: 28649750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasopressin and Related Peptides; Potential Value in Diagnosis, Prognosis and Treatment of Clinical Disorders.
    Szczepanska-Sadowska E; Zera T; Sosnowski P; Cudnoch-Jedrzejewska A; Puszko A; Misicka A
    Curr Drug Metab; 2017; 18(4):306-345. PubMed ID: 28117000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Value of Copeptin in Chronic Kidney Disease: From General Population to End-Stage Renal Disease.
    Golembiewska E; Machowska A; Stenvinkel P; Lindholm B
    Curr Protein Pept Sci; 2017; 18(12):1232-1243. PubMed ID: 28714397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasopressin, from Regulator to Disease Predictor for Diabetes and Cardiometabolic Risk.
    Melander O
    Ann Nutr Metab; 2016; 68 Suppl 2():24-8. PubMed ID: 27299865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age differences in the renal tubular response to antidiuretic hormone.
    MILLER JH; SHOCK NW
    J Gerontol; 1953 Oct; 8(4):446-50. PubMed ID: 13130853
    [No Abstract]   [Full Text] [Related]  

  • 18. Introduction: Vasopressin therapy.
    Whellan DJ
    Heart Fail Rev; 2009 Jun; 14(2):57-8. PubMed ID: 18989773
    [No Abstract]   [Full Text] [Related]  

  • 19. Angiotensin II in the paraventricular nucleus stimulates sympathetic outflow to the cardiovascular system and make vasopressin release in rat.
    Khanmoradi M; Nasimi A
    Neurosci Lett; 2016 Oct; 632():98-103. PubMed ID: 27565052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigational vasopressin receptor modulators in the pipeline.
    Favory R; Salgado DR; Vincent JL
    Expert Opin Investig Drugs; 2009 Aug; 18(8):1119-31. PubMed ID: 19589090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.